TODD FOLEY

Profile

First Name

: TODD

Middle Name

:

Last Name

: FOLEY

Related Companies
Titles
Company Name
Related People
DIRECTOR
RHYTHM PHARMACEUTICALS, INC.
CHRISTIAN DE LA TOUR, KEITH GOTTESDIENER, BART HENDERSON, VAUGHAN KAILIAN, EDWARD MATHERS, STEVEN ST. PETER, LOU TARTAGLIA
DIRECTOR
ZALICUS INC.
JASON F. COLE, MARK H.N. CORRIGAN, SALLY W. CRAWFORD, CHRISTOPHER C. GALLEN, FRANK HAYDU, WILLIAM HUNTER, MICHAEL G. KAUFFMAN, W. JAMES O-SHEA, JUSTIN A. RENZ, HARTLEY T. RICHARDSON
DIRECTOR
CELLADON CORP
GREGG ALTON, FOUAD AZZAM, CHARLES BRAMLAGE, KENNETH R. CHIEN, GRAHAM COOPER, DAVID A. CORY, BARBARA DALTON, THOMAS J. DIETZ, EDGAR G. ENGLEMAN, ANTHONY B. EVNIN, JOSHUA FUNDER, JEFFREY S. GLENN, NINA KJELLSON, JOHAN KORDEL, REBECQUE LABA, EDUARDO BRUNO MARTINS, MICHAEL NARACHI, DANIEL OMSTEAD, JOANNE QUAN, ANDREW E. SENYEI, JAMES P. SHAFFER, LAUREN SILVERMAN, JAMES H. WELCH, ASISH XAVIER, KRISZTINA ZSEBO
DIRECTOR
SELEXYS PHARMACEUTICALS CORP
RICHARD ALVAREZ, DAVID FALCONER, PHILIP JONES, PHILIP JONES, M.D., DAVID KEISER, RODGER MCEVER, RODGER MCEVER, M.D., WILLIAM PAIVA, WILLIAM PAIVA, PH.D., SCOTT ROLLINS, SCOTT ROLLINS, PH.D., RUSSELL ROTHER, TOM WALKER
DIRECTOR
PROTEON THERAPEUTICS INC
HUBERT BIRNER, HUBERT BIRNER, PH. D., GAREN BOHLIN, STEVEN K. BURKE, STEVEN K. BURKE, M.D., SCOTT A. CANUTE, GEORGE ELDRIDGE, GEORGE A. ELDRIDGE, F. NICHOLAS FRANANO, JOHN G. FREUND, JOHN G. FREUND, M.D., DANIEL P. GOTTLIEB, TIM HAINES, PAUL J. HASTINGS, STEPHEN HOFFMAN, TONY KINGSLEY, DMITRY KOBYZEV, MATTHEW P. KOWALSKY, JONATHAN LEFF, DAVID G. LOWE, TIMOTHY NOYES, TIMOTHY P. NOYES, BRENDAN O-LEARY, GREGORY D. PHELPS, DEAN PROFIS, STEVEN ST. PETER, E. SCOTT TONER
DIRECTOR
ICONIC THERAPEUTICS INC
BRUCE COHEN, KIRK DORNBUSH, WILLIAM GREENE, JULIA GREGORY, PETER HIRTH, JOHAN KORDEL, BRUCE ROBERTSON, JON SODERSTROM
DIRECTOR
VALERITAS INC
JOHN BARR, MICHAEL BIGHAM, JAMES DENTZER, WILLIAM DUKE, ITTAI HAREL, VAUGHN KAILIAN, STEVE LAPORTE, DANIEL PELAK, KRISTINE PETERSON, PAUL QUEALLY, JOHN RYAN, SEAN TRAYNOR
DIRECTOR
TETHEREX PHARMACEUTICALS CORP
RICHARD ALVAREZ, DAVID FACLONER, PHILIP JONES, M.D., DAVID KEISER, RODGER MCEVER, M.D., SCOTT ROLLINS, PH.D., RUSSELL ROTHER, RUSSELL ROTHER, PH.D., SCOTT SAMARA, JONATHAN STOCKER, PH.D.
DIRECTOR
CLINICAL INK, INC.
STEPHEN H. COLTRIN, ROGER LAVERN DAVENPORT, ANSBERT GADICKE, BRAD GEESAMAN, MORANA JOVAN-EMBIRICOS, MATT KING, MATTHEW KING, ROBERT KNIEJSKI, MICHAEL LESTER, THOMAS W LITTLEJOHN, III, RICHARD MALCOLM, SCOTT MILTENBERGER, DOUGLAS E PIERCE, JR., DOUGLAS E. PIERCE, JR., CHRISTOPHER H RAMM, CHRISTOPHER H. RAMM, TONY ROSENBERG, JOE SCHMIDT, EDWARD S. SEGUINE, EDWARD S SEGUINE, JR., EDWARD S. SEGUINE, JR., MICHAEL SORENSEN, PHIL WAUGH, PHILIP RS WAUGH, JR.
EXECUTIVE OFFICER, DIRECTOR
SEMMA THERAPEUTICS, INC.
DANIEL AUERBACH, MITCH FINER, MITCHELL FINER, MARK FISHMAN, STEPHEN KNIGHT, ROBERT MILLMAN, KEVIN RAIDY, WILLIAM SAHLMAN, BASTIANO SANNA, JIM SCOPA, ELIZABETH STONER, KINGSLEY TAFT
DIRECTOR
RHYTHM METABOLIC, INC.
JEAN CHRISTOPHE, NEIL EXTER, KEITH GOTTESDIENER, BART HENDERSON, CHRISTOPHE JEAN, EDWARD T. MATHERS, DAVID J. MCGIRR, DAVID P. MEEKER, M.D., JONATHAN SILVERSTEIN
DIRECTOR
RHYTHM PHARMACEUTICALS, INC.
JEAN CHRISTOPHE, NEIL EXTER, KEITH GOTTESDIENER, BART HENDERSON, CHRISTOPHE JEAN, EDWARD T. MATHERS, DAVID J. MCGIRR, DAVID P. MEEKER, M.D., JONATHAN SILVERSTEIN
DIRECTOR
ENTRADA THERAPEUTICS, INC.
CHRISTINE BRENNAN, JOHN CROWLEY, JOHN F. CROWLEY, DIPAL DOSHI, NATHAN DOWDEN, ANJA HARMEIER, PETER KIM, NERISSA KREHER, CAROLE NUECHTERLEIN, KUSH PARMAR, KUSH M. PARMAR, DEHUA PEI, MARIO SALTARELLI, NATARAJAN SETHURAMAN, LOUIS TARTAGLIA, KORY WENTWORTH
DIRECTOR
MOAT BIOTECHNOLOGY CORP
RICHARD ALVAREZ, RICHARD A. ALVAREZ, TETHEREX PHARMACEUTICALS CORPORATION, TETHEREX PHARMACEUTICALS A. CORPORATION, TODD A. FOLEY, PHILIP JONES, PHILIP A. JONES, PHILLIP JONES, MICHAEL MORADI-ARAGHI, SCOTT ROLLINS, SCOTT A. ROLLINS, RUSSELL ROTHER, RUSSELL A. ROTHER, RUSSELL P. ROTHER
DIRECTOR
CROSSBOW THERAPEUTICS, INC.
SAKAE ASANUMA, CHARLES BAUM, ALEXANDRA CANTLEY, ALON LAZARUS, IRENA MELNIKOVA, BRIGGS MORRISON, ALEXANDER NOLTE, GERALDINE PAULUS, DMITRI WIEDERSCHAIN
DIRECTOR
FIREFLY BIO, INC.
PANKAJ BHARGAVA, PETER COLABUONO, JEREL DAVIS, JOHN FLYGARE, BERNHARD GEIERSTANGER, SCOTT HIRSCH, ALEXANDER MAYWEG
DIRECTOR
AKTIS ONCOLOGY, INC.
KEN HERRMANN, HELEN S. KIM, ANDREW LEVIN, OLEG NODELMAN, MATTHEW RODEN, SHULAMIT RON-BIGGER, LLOYD SEGAL
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-10-20
D
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2025-10-03 
2025-09-30
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2025-09-17 
2024-10-02
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-09-20 
2024-03-26
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-12-18 
2023-04-12
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-03-29 
2022-10-11
D/A
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Debt 
2022-06-29 
2022-09-21
D
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Debt 
2022-06-29 
2021-04-13
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-03-29 
2020-12-16
D
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2020-12-03 
2019-12-26
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2018-12-14 
2019-04-26
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-04-15 
2019-02-26
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-11-27 
2018-06-19
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2018-06-05 
2018-03-06
D
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2018-02-20 
2017-12-28
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Debt 
2017-12-13 
2017-12-05
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-11-27 
2017-01-20
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2017-01-06 
2016-11-02
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-12-24 
2016-03-31
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-03-19 
2016-01-12
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-12-24 
2015-12-10
D/A
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2015-08-03 
2015-10-09
D/A
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Debt 
2015-05-18 
2015-08-12
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-08-03 
2015-06-17
D
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Debt 
2015-05-18 
2015-04-07
D/A
Link
OTHER 
 
$5,000,001 - $25,000,000 
Equity 
2015-03-19 
2015-04-02
D
Link
OTHER 
 
$1,000,001 - $5,000,000 
Equity 
2015-03-19 
2015-04-01
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-03-19 
2015-02-23
D
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2015-02-09 
2015-02-23
D/A
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2012-09-17 
2014-07-07
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-06-23 
2014-05-28
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-05-13 
2014-04-23
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-04-14 
2014-02-19
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2013-09-04 
2013-10-25
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Debt 
2013-10-15 
2012-10-02
D
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2012-09-17 
2012-05-08
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-01-27 
2010-12-22
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
$5,000,001 - $25,000,000 
 
2010-12-22 
2010-08-30
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2010-03-09 
2010-03-22
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2010-03-09